Vanda Pharmaceuticals stock surges after the FDA approves its new Bipolar I drug
Original source: https://www.investing.com/news/stock-market-news/vanda-pharmaceuticals-stock-surges-after-the-fda-approves-its-new-bipolar-i-drug-4517428
Read More »US FDA approves Vanda Pharmaceuticals’ motion sickness drug
Original source: https://www.investing.com/news/stock-market-news/us-fda-approves-vanda-pharmaceuticals-motion-sickness-drug-4426090
Read More »Earnings call: Rigel Pharmaceuticals reports robust sales growth in Q2
Original source: https://www.investing.com/news/stock-market-news/earnings-call-rigel-pharmaceuticals-reports-robust-sales-growth-in-q2-93CH-3565383
Read More »Pro Research: Wall Street examines BioMarin Pharmaceutical’s prospects
Original source: https://www.investing.com/news/stock-market-news/pro-research-wall-street-examines-biomarin-pharmaceuticals-prospects-93CH-3279834
Read More »Pro Research: Wall Street delves into Vertex Pharmaceuticals
Original source: https://www.investing.com/news/stock-market-news/pro-research-wall-street-delves-into-vertex-pharmaceuticals-93CH-3279957
Read More »Pro Research: Wall Street delves into Alnylam Pharmaceuticals
Original source: https://www.investing.com/news/stock-market-news/pro-research-wall-street-delves-into-alnylam-pharmaceuticals-93CH-3248977
Read More »Vertex Pharmaceuticals stock gains for second consecutive day amid bullish market
Original source: https://www.investing.com/news/stock-market-news/vertex-pharmaceuticals-stock-gains-for-second-consecutive-day-amid-bullish-market-93CH-3207794
Read More »